Synthesis, pharmacological evaluation and docking studies of N-(benzo[d]thiazol-2-yl)-2-(piperazin-1-yl)acetamide analogs as COX-2 inhibitors.

doi:10.1016/j.bmcl.2011.12.062

Paper

Synthesis, pharmacological evaluation and docking studies of N-(benzo[d]thiazol-2-yl)-2-(piperazin-1-yl)acetamide analogs as COX-2 inhibitors.

Published Jan 15, 2012 · N. M. Raghavendra, A. Jyothsna, Alapati Venkateswara Rao

Bioorganic & medicinal chemistry letters

Q2 SJR score

34

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Study Snapshot

N-(benzo[d]thiazol-2-yl)-2-(piperazin-1-yl)acetamide analogs show potential as non-toxic anti-inflammatory agents by binding to COX-2 enzyme and exhibiting in vivo anti-inflammatory activity.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Synthesis, pharmacological evaluation and docking studies of N-(benzo[d]thiazol-2-yl)-2-(piperazin-1-yl)acetamide analogs as COX-2 inhibitors.

Sign up to use Study Snapshot

References

Citations